Potassium Carbonate → HCID 137108727, 화합물
반응식
C([O:9][CH2:10][C@@H:11]1[CH2:15][C@@H:14]([NH:16][S:17]([CH3:20])(=[O:19])=[O:18])[C@H:13]([N:21]2[C:25]3[N:26]=[C:27]([NH2:31])[NH:28][C:29](=[O:30])[C:24]=3[S:23][C:22]2=[O:32])[O:12]1)(=O)C1C=CC=CC=1.C([O-])([O-])=O.[K+].[K+]>CO>[NH2:31][C:27]1[NH:28][C:29](=[O:30])[C:24]2[S:23][C:22](=[O:32])[N:21]([C@H:13]3[C@H:14]([NH:16][S:17]([CH3:20])(=[O:19])=[O:18])[CH2:15][C@@H:11]([CH2:10][OH:9])[O:12]3)[C:25]=2[N:26]=1참가 물질
4
실험 절차
To a solution of [(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-(methanesulfonamido)tetrahydrofuran-2-yl]methyl benzoate (compound 33d, crude, 80 mg, 0.54 mmol) in MeOH (5 mL) was added K2CO3 (80 mg, 0.6 mmol). After being stirred at room temperature for 5 hours, the reaction mixture was concentrated in vacuo and the residue was purified by preparative HPLC to afford 8.0 mg of N-[(2R,3R,5S)-2-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3-yl]methanesulfonamide (Example 33) as a white solid.